Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | THRB | P10828 | 1/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | DGKA | P23743 | 1/20 | 0.32 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propylene Glycol SCHEMBL28592512 | 0.87 | TSHR (0.54) | USP2TSHRHSD17B10KDM4ELMNA | |
| SCHEMBL24053181 | 0.86 | USP2 (0.59) | USP2HSD17B10KDM4ELMNADUSP3 | |
| SCHEMBL5344357 | 0.85 | USP2 (0.52) | USP2TSHRHSD17B10KDM4ELMNA | |
| SCHEMBL3252403 | 0.85 | USP2 (0.55) | USP2TSHRHSD17B10KDM4ELMNA | |
| SCHEMBL13135366 | 0.84 | USP2 (0.48) | USP2TSHRHSD17B10KDM4ELMNA | |
| SCHEMBL5198804 | 0.83 | USP2 (0.48) | USP2TSHRHSD17B10KDM4ELMNA | |
| SCHEMBL17780022 | 0.83 | USP2 (0.53) | USP2TSHRHSD17B10KDM4ELMNA | |
| SCHEMBL9354591 | 0.82 | USP2 (0.47) | USP2TSHRHSD17B10KDM4ELMNA | |
| SCHEMBL19643118 | 0.82 | TSHR (0.48) | TSHRHSD17B10TDP1 | |
| SCHEMBL9679319 | 0.82 | TSHR (0.48) | TSHRHSD17B10TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599435-B1 | REACTION PRODUCTS OF 2-PROPYLHEPTANOL WITH 1-HALOGEN-2,3-EPOXYPROPANES AND 1-HYDROXY-2,3-EPOXYPROPANE | BASF SE (DE) | 2012-03-07 | — | — | EP | disclosed |
| EP-1816115-A2 | Method for producing glycidiyl ether | Kao Corporation (JP) | 2007-08-08 | — | — | EP | disclosed |
| US-20070149826-A1 | METHOD FOR PRODUCING A REACTION PRODUCT | KAO CORPORATION (JP) | 2007-06-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070149826-A1 | METHOD FOR PRODUCING A REACTION PRODUCT | SQLE, HAO2, POLR1C | USP2 2880/4885TSHR 3244/4885HSD17B10 333/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.